0QXX.L - Molecular Partners AG

LSE - LSE Delayed price. Currency in CHF
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-10.59%
S&P500 52-week change 314.65%
52-week high 37.64
52-week low 35.28
50-day moving average 35.80
200-day moving average 36.09

Share statistics

Avg vol (3-month) 31.69k
Avg vol (10-day) 33.81k
Shares outstanding 521.18M
Implied shares outstanding 6N/A
Float 814.42M
% held by insiders 119.83%
% held by institutions 143.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin -251.94%
Operating margin (ttm)-256.85%

Management effectiveness

Return on assets (ttm)-11.46%
Return on equity (ttm)-20.57%

Income statement

Revenue (ttm)19.87M
Revenue per share (ttm)0.61
Quarterly revenue growth (yoy)-98.20%
Gross profit (ttm)138.85M
EBITDA -50.15M
Net income avi to common (ttm)-50.05M
Diluted EPS (ttm)3.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)232.37M
Total cash per share (mrq)7.14
Total debt (mrq)4.55M
Total debt/equity (mrq)2.05
Current ratio (mrq)15.44
Book value per share (mrq)6.82

Cash flow statement

Operating cash flow (ttm)-61.54M
Levered free cash flow (ttm)-38.27M